Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
0.00%
NET PROFIT MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.02%
median of 811 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Oncolytics Biotech Inc.
Market Cap
$59.51M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.49M
Net Profit Margin
0.00%
TTM Avg
-36932.26%
3Y Avg
-34526.76%
5Y Avg
-23017.84%
Market Cap
$59.38M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$60.49M
Net Profit Margin
-34.06%
TTM Avg
-499.05%
3Y Avg
-249.52%
5Y Avg
-166.35%
Market Cap
$59.90M
Net Profit Margin
-86687.50%
TTM Avg
-43373.76%
3Y Avg
-21686.88%
5Y Avg
-14457.92%
Market Cap
$59.90M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-69.82%
5Y Avg
-186.89%
Market Cap
$61.20M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.54M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.09M
Net Profit Margin
-1507600.00%
TTM Avg
-25517.85%
3Y Avg
-13465.42%
5Y Avg
-10648.78%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oncolytics Biotech Inc. (ONCY) | $59.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fractyl Health, Inc. (GUTS)vs › | $59.49M | 0.00% | -36932.26% | -34526.76% | -23017.84% |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.49M | -34.06% | -499.05% | -249.52% | -166.35% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.90M | -86687.50% | -43373.76% | -21686.88% | -14457.92% |
| Adicet Bio, Inc. (ACET)vs › | $59.90M | 0.00% | 0.00% | -69.82% | -186.89% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Boundless Bio, Inc. (BOLD)vs › | $57.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Talphera, Inc. (TLPH)vs › | $57.09M | -1507600.00% | -25517.85% | -13465.42% | -10648.78% |
| OKYO Pharma Limited (OKYO)vs › | $56.40M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | -1186.15% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | -1068.85% |
| 2006-06-30 | -892.69% |
| 2006-03-31 | -1024.75% |
| 2005-12-31 | -4247.89% |
| 2005-09-30 | -1432.23% |
| 2005-06-30 | -1758.99% |
| 2005-03-31 | -971.58% |
| 2004-12-31 | -1947.85% |
| 2004-09-30 | -1595.89% |
| 2004-06-30 | -1739.83% |
| 2004-03-31 | -2280.44% |
| 2003-12-31 | -1338.28% |
| 2003-09-30 | -1785.34% |
| 2003-06-30 | -9458.05% |
| 2003-03-31 | -2581.23% |
| 2002-12-31 | -3469.40% |
| 2002-09-30 | -3768.86% |
